Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reissue Patent
2006-04-11
2006-04-11
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S725000, C514S451000, C514S732000
Reissue Patent
active
RE039061
ABSTRACT:
The present invention relates to novel compositions based on hydrated lipidic lamellar phases or liposomal compositions, prepared by combining different lipid molecules, synthetic and/or from natural sources, said compositions comprising at least one of a) labd-13-ene-8α, 15-diol and/or derivatives thereof; b) labd-14-ene-8, 13-diol or derivatives thereof; c) 3β-hydroxy-labd-14-ene-8, 13-epoxy and/or derivatives thereof, d) a plant extract containing the aforementioned labdanes or derivatives thereof. The compositions of the invention exhibit cytotoxicity against cancerous cells and are utilized for the treatment of tumors and leukemias.
REFERENCES:
patent: 4529561 (1985-07-01), Hunt
patent: 5156766 (1992-10-01), Behan
patent: 5510113 (1996-04-01), Bonte
Ahmed, A. “A diterpene xyloside fromConza steudellii.” Phytochemistry, 1991, 30, 611-12.
Alcarez, M.J.; Garcia-Ochoa, S.; Jimenez, M.J.; Valverde, S.; Villar, A. “A derivative of ent-13-epi-manoyl oxidase isolated fromSideritis javalambrensis.” Phytochemistry, 1989, 28, 1267-8.
Alcaraz, M.J.; Jimenez, M.J.; Valverde, S.; Sanz, J.; Rabanal, R.M. “Anti-inflammatory compounds fromSideritis javalambrensisN-hexane extract.” J. Nat. Prod. 1989, 52, 1088-1091.
Atanasova-Shopova, S.; Rusinov, K. Izv. Inst. Fiziol. Bulg. Akad. Nauk., 1970, 13, 89. “Experimental studies on certain effects of the essential oil of Salvia Sclarea L. on the central nervous system.” Chem. Abstr. 74, 123553 m, 1971, 89-95.
Ayafor, FJ; Tchuendem, MHK; Nyasse, B; Tillequin, F; Anke, H. “Novel bioactive diterpenoids fromAframomum aulacocarpos.” J. Natural Products, 1994, 57(7), 917-23.
Barua, S.K.; Saha, S.K.; Patra, A.; Mitra, A.K. “The structure and stereochemistry of phlogantholide-A, a diterpene fromPhlogacanthus thyrsiflorus.” Phytochemistry, 1985, 24, 2037-39.
Bernardirelli, G.; Vial, C.; Starkemann, S.; Naf, F. “Structure and absolute configuration of (−)-sclareol-8-acetate.” Acta Cryst., 1988, 44C, 715-7.
Bhat, S.V.; Balwa, B.S.; Dornauer, H.; de Souza, N.J.; Fehlhaber, H.W. “Structures and stereochemistry of new labdane diterpenoids fromColeus forskohlii briq.” Tetrahedron Lett., 1977, 1669-72.
Bohlmann, F.; Suwita, A.; King, R.M.; Robinson, H. “New ent labdane derivatives fromAustroeupatorium-chaparense.” Phytochemistry, 1980, 19, 111-4 (in German with English Abstract).
Bohlmann, F.; Banerjee, S.; Jakupovic, J.; Grenz, M.; Mirsa, L.N.; Schmeda-Hirschmann, G.; King, R.M. “Clerodane and labdane diterpenoids fromBaccharisspecies.” Phytochemistry, 1985, 24, 511-5.
Bohlmann, F.; Hartono, L.; Zdero, C.; Jakupovic, J. “Constituents of the genusOxylobus.” Phytochemistry, 1985, 24, 1111-2.
Brodsky, A; Davio, C; Shayo, C; Lemos Legnazzi, B; Barbosa, M. “Forskolin induces U937 cell line differentiation as a result of a sustained cAMP elevation.” Eur. J. Pharmacol., 1998, 350(1), 121-7.
Calabuig, M.T.; Cortes, M.; Francisco, C.G.; Hernadez, R.; Suarez, E. “Labdane diterpenes fromCistus symphytifolius.” Phytochemistry, 1981, 20, 2255-8.
Cambie, R.C.; Jablin, K.N.; Preston, A.F. “Chemistry of the podocarpaceae. XLIII. Utilization of 8α,13-epoxylabd-14-ene and related compounds for the preparation of ambergris-type compounds.” Aust. J. Chem. 1972, 25, 1767-78.
Caputo, R.; Mangoni, L.; Monaco, P. “Diterpenes ofAraucaria excelsa.” Phytochemistry, 1972, 11, 839-41.
Caputo, R.; Mangoni, L.; Monaco, P.; Pelosi, L.; Previtera, L. “Neutral diterpenes fromAraucaria bidwilli.” Phytochemistry, 1976, 15, 1401-2.
Cardenas, L.C.; Rodrigez, J.; Rigueza, R.; Chamy, M.M. “Mitrariosides, five bitter labdane glycoside fromMitraria coccinea(Gesneriaceae).” Liebigs Ann. Chem. 1992, 665-8.
Carman, R.M. “Optical rotation and structure in the labdane series of diterpenoids.” Aust. J. Chem., 1966, 19, 629-42.
Carman, R.M.; Craig, W.J.; Shaw, I.M. “Diterpenoids. XXXI. Three new resin acids.” Aust. J. Chem., 1973, 26, 209-14.
Casadevall et al. “Contraction de cycle a partir de la tosyloxy-8 bicyclo[4.2.0]octanone-7 cis.” Tetrahedron, 1975, 31, 757-63 (in French with English abstract).
Chen, TC; Hinton, DR; Zidovetski, R; Hoffman, FM. “Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas.” Lab. Invest., 1998 78(2), 165-74.
Chinou, I.; Demetzos, C.; Harvala, C.; Roussakis, C.; Verbist, J.F. “Cytotoxic and antibacterial labdane-type diterpenes from the aerial parts ofCistus incanussubsp.creticus.” Planta Med., 1994, 60, 34-6.
Colletta, G; Girafici, AM; Consiglio, E; Vecchio, G. “Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line.” Oncogene Res, 1987, 1(4), 459-66.
Cunningham, A.; Martin, S.S.; Langenheim, J.H. “Resin acids from two amazonian species ofHymenaea.” Phytochemistry, 1973, 12, 633-5.
Darias, V.; Bravo, L.; Rabanal, R.; Sanchez-Mateo, C.C.; Martin-Herrera, D.A. “Cytostatic and antibacterial activity of some compounds isolated from several lamiaceae species from the Canary Islands.” Planta Med., 1990, 56, 70-72.
De Pascual, T.; Urones, J.G.; Mateos, F.G. “Terpenoides monohidroxilados de la gomorresina deCistus Ladaniferus L.” Ann. Quim., 1977, 73, 1024-8 (in Italian with English summary).
De Pascual, T.; Urones, J.G.; Marcos, I.S.; Nunez, L.; Basabe, P. “Diterpenoids and flavonoids fromCistus palinhae.” Phytochemistry, 1983, 22, 2805-8.
De Pascual, T.; Bellido I.S.; Basade, P.; Marcos, I.S.; Ruano, L.F.; Urones, J.G. “Labdane diterpenoids fromCistus labdaniferus.” Phytochemistry, 1982, 21, 899-901.
Demetzos, C.; Harvala, C.; Phillianos, S.M.; Skaltsounis, A.L. “A new labdane-type diterpene and other compounds from the leaves ofCistus incanusssp.cretus.” J. Nat. Prod., 1990, 53, 1365-68.
Detmetzos, C.; Mitaku, S.; Couladis, M.; Harvala, C.; Kokkinopoulos, D. “Natural metabolites of ent-13-epi-manoyl oxide and other cytotoxic diterpenes from the resin “LADANO” ofCistus creticus.” Planta Med., 1994, 60, 590-591.
Demetzos, C.; Mitaku, S.; Skaltsounis, A.L.; Couladis, M.; Harvala, C.; Libot, F. “Diterpene esters of malonic acid from the resin “LADANO” ofCistus creticus.” Phytochemistry, 1994, 35, 979-81.
Demetzos, C.; Stahl, M.; Anastassaki, T.; Gazouli, M.; Tzouvelekis, L.; Rallis, M. “Chemical analysis and antimicrobial activity of the resin ladano, or its essential oil and of the isolated compounds.” Planta Med., 1998, 65, 76-78.
Dimas K.; Demetzos, C.; Marsellos, M.; Sotiriadou, R.; Malamas, M.; Kokkinopoulos, D. “Cytotoxic acttivity of labdane type diterpenes against human leukemic cell lines in vitro.” Planta Med., 1998, 64, 208-11.
Dimas, K.; Demetzos, C.; Mitaku, S.; Marsellos, M.; Tzavaras, T.; Kokkinopoulos, D. “Cytotoxic activity and antiproliferative effects of a new semi-synthetic derivative of ent-13β-hydroxy-13-epi-manoyl oxide on human leukemic cell lines.” Anticancer Res., 1999, 19, 4065-72.
Dimas, K; Kokkinopoulos, D; Demetzos, C; Marselos, M; Sotiriadou, R; Malamas, M. “The effect of sclareol on growth and cell cycle progression of human leukemic cell lines.” Leukemia Res., 1999, 23; 217-34.
Fernandez, C.; Fraga, M.B.; Hernandez, C.M. “Diterpenes fromSideritis nutans.” Phytochemistry, 1986, 25, 2825-27.
Fukuyama, Y.; Yokoyama, R.; Ohsaki, A.; Takahashi, H.; Minami, H. “An example of the co-occurrence of enantiomeric labdanetype diterpenes in the leaves ofMimosa hostilis.” Chem. Pharm. Bull., 1999, 47, 454-5.
Fullas, F; Houssain, RA; Chai, HB; Pezzuto, JM; Soejarto, DD; Kinghorn, AD. “Cytotoxic constituents ofBaccharis gaudichaudiana.
Anastassaki Thalia
Angelopoulou Demetra
Demetzos Constantinos
Dimas Constantinos
Kokkinopoulos Demetrios
Jones Day
Kishore Gollamudi S.
Medexis S.A.
LandOfFree
Pharmaceutical formulations comprising labdanes for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations comprising labdanes for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations comprising labdanes for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3539121